TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Wonder drug for hepatitis C has $90,000 price tag

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

'American Coyotes' Series

Traveling by Jeep, boat and foot, Tribune-Review investigative reporter Carl Prine and photojournalist Justin Merriman covered nearly 2,000 miles over two months along the border with Mexico to report on coyotes — the human traffickers who bring illegal immigrants into the United States. Most are Americans working for money and/or drugs. This series reports how their operations have a major impact on life for residents and the environment along the border — and beyond.

By The Associated Press
Tuesday, June 17, 2014, 8:36 p.m.
 

WASHINGTON — Your money or your life?

Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.

Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are balking at the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.

Yet if Sovaldi didn't exist, insurers would still be paying in the mid-to-high five figures to treat the most common kind of hepatitis C, a new pricing survey indicates. Some of the older alternatives involve more side effects, and are less likely to provide cures.

So what's a fair price?

The cost of this breakthrough drug is highlighting cracks in the health care system at a time of heightened budget concerns. The Obama administration has a huge political stake in controlling treatment costs, but its critics may cry rationing.

“People are going to want to try to dodge this hot potato,” says economist Douglas Holtz-Eakin.

For insurers, there's a frustrating twist: For each middle-aged person they pay to cure with Sovaldi, any financial benefits from preventing liver failure are likely to accrue to Medicare, not to them.

More than 3 million Americans carry the hepatitis C virus, and many don't realize it. It's a public health concern since the disease can be transmitted by contact with infected blood, and sometimes through sexual activity. Health officials advise all baby boomers to get tested.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. Planned Parenthood recordings release halted by judge
  2. Suspect in South Carolina church shooting wants to plead guilty to hate crimes, attorney says
  3. Baltimore slayings climb to level unseen in decades
  4. Amid 4-year drought, fears rise of trees dying, falling in California
  5. Fires’ fury unabated in California
  6. Despite U.S. dollars and bombs, effort failing to squash ISIS
  7. Global lion population falling primarily because of loss of habitat, experts say
  8. Analysts expect French laboratory will be able to provide details from examination of jet part
  9. Fetal parts in Planned Parenthood lab shown in 4th video
  10. Feds eye use of federal dollars for ads for for-profit colleges
  11. Family finds $1M gold treasure in Florida